Professor of Surgery, UCLA
General Surgery
Dr. Armando E. Giuliano, MD
|
|
Give Review
Armando E. Giuliano, MD works in the field of General Surgery. He graduated from University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine has a rank of 10 in research and a 19 in primary care He received 10 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California", "Redbook Magazine: Top Breast Cancer Doctors", "Super Doctor", "Top MD", "Fellow (FACS)" and "Most Compassionate Doctor". Armando Giuliano is also a published doctor. He has 100 paper published. The most recent paper is: Sentinel Node Biopsy and Improved Patient Care. Armando Giuliano is registered with Medicare.
Publications
- Sentinel Node Biopsy and Improved Patient Care.
- FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer.
- Evaluation of the Stage IB Designation of the American Joint Committee on Cancer Staging System in Breast Cancer.
- Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial.
- Margins: a status report from the annual meeting of the american society of Breast surgeons.
- Comparison of Nodal Metastasis Between BRCA Mutation Carriers and Non-BRCA Mutation Carriers with Breast Cancer.
- Applicability of the ACOSOG Z0011 Criteria in Women with High-Risk Node-Positive Breast Cancer Undergoing Breast Conserving Surgery.
- Reply to I.A. Voutsadakis et al and A. Goyal et al.
- Triple-Negative Breast Cancer is Not Associated with Increased Likelihood of Nodal Metastases.
- Long-term clinical impact of sentinel lymph node biopsy in Breast cancer and cutaneous melanoma.
- Donald L. Morton, 1935-2014.
- Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
- Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stag...
- Personalizing Breast Cancer Staging by the Inclusion of ER, PR, and HER2.
- Breast-Conserving Therapy for Triple-Negative Breast Cancer.
- Management of Papillary Lesions of the Breast: Can Larger Core Needle Biopsy Samples Identify Patients Who May Avoid Surgical Excision?
- Management of the axilla.
- Assessment of DNA methylation status in early stages of Breast cancer development.
- Impact of Multifocality and Lymph Node Metastasis on the Prognosis and Management of Microinvasive Breast Cancer.
- Predicting nipple-areolar involvement using preoperative Breast MRI and primary tumor characteristics.
- Preliminary results: double lumpectomies for multicentric Breast carcinoma.
- Surgical delay of the nipple-areolar complex: a powerful technique to maximize nipple viability following nipple-sparing mastectomy.
- Epigenetic regulation of cancer stem cell genes in triple-negative Breast cancer.
- Senior peer counseling by telephone for psychosocial support after Breast cancer surgery: effects at six months.
- Preoperative Breast MRI in the Surgical Treatment of Ductal Carcinoma In Situ.
- Local recurrence risk factors in women treated with BCT for early-stage Breast cancer.
- Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer.
- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive Breast cancer.
- To Cut Is to Cure: Can We Really Apply Z11 in Practice?
- Nipple-Sparing Mastectomy in 99 Patients With a Mean Follow-up of 5Â Years.
- Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative Breast cancer.
- Basal-Like Breast Cancer Defined by FOXC1 Expression Offers Superior Prognostic Value: A Retrospective Immunohistochemical Study.
- Axillary dissection vs no axillary dissection in women with invasive Breast cancer and sentinel node metastasis: a randomized clinical trial.
- The Florid Subtype of Lobular Carcinoma In Situ: Marker or Precursor for Invasive Lobular Carcinoma?
- Thioredoxin-like 2 regulates human Cancer cell growth and metastasis via redox homeostasis and NF-κB signaling.
- Direct serum assay for microRNA-21 concentrations in early and advanced Breast cancer.
- Local and regional control in Breast cancer: role of sentinel node biopsy.
- B7-h3 ligand expression by primary Breast cancer and associated with regional nodal metastasis.
- Sentinel lymph node biopsy for papillary thyroid Cancer: 12 years of experience at a single institution.
- Chemotherapy and Breast reconstruction.
- Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College ...
- Adherence to the National Quality Forum (NQF) Breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.
- Invasive lobular vs. ductal Breast cancer: a stage-matched comparison of outcomes.
- FOXC1 is a potential prognostic biomarker with functional significance in basal-like Breast cancer.
- Long-term follow-up confirms the oncologic safety of sentinel node biopsy without axillary dissection in node-negative Breast cancer patients.
- Underuse of axillary dissection for the management of sentinel node micrometastases in Breast cancer.
- Impact of micrometastases in the sentinel node of patients with invasive Breast cancer.
- MRI versus ultrasonography and mammography for preoperative assessment of Breast cancer.
- Survey of ASCO members on management of sentinel node micrometastases in Breast cancer: variation in treatment recommendations according to specialty.
- N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance Cancer cell killing.
- Quantification of LINE1 in circulating DNA as a molecular biomarker of Breast cancer.
- A role for ceramide in driving Cancer cell resistance to doxorubicin.
- Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral Breast cancer.
- A randomized clinical trial on sentinel lymph node dissection versus axillary dissection: a matter of technique.
- SSO approved training programs in Breast cancer care.
- Nodal stage classification for Breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training.
- An update on prognosis in Breast cancer patients with extensive axillary disease.
- The prognostic significance of micrometastases in Breast cancer: a SEER population-based analysis.
- Outcomes for women with ductal Carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
- Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007.
- Detection of circulating tumor cells in early-stage Breast cancer metastasis to axillary lymph nodes.
- Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary Hyperparathyroidism and its effect on sestamibi imaging.
- Sentinel node mapping for Breast cancer: progress to date and prospects for the future.
- Dietary fat reduction and Breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.
- Proteomic profiling of primary Breast cancer predicts axillary lymph node metastasis.
- Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid Carcinoma.
- What is the value of axillary dissection or sentinel node biopsy in patients with ductal Carcinoma in situ?
- Prediction of Breast tumor progression by integrity of free circulating DNA in serum.
- Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage Breast cancer patients.
- Sentinel lymph node biopsy for local recurrence of Breast cancer after Breast-conserving therapy.
- Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.
- The practical value of prediction: a semireliable assistant.
- The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for Breast cancer metastases.
- Lymphatic mapping and sentinel lymph node biopsy in early-stage Breast carcinoma: a metaanalysis.
- Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage Breast cancer.
- Nonsentinel node metastases in Breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection.
- Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breas...
- Does Breast massage push tumor cells into sentinel nodes?
- Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant Breast cancer cells to anticancer drugs.
- Distinct hypermethylation profile of primary Breast cancer is associated with sentinel lymph node metastasis.
- Sentinel lymph node mapping for primary Breast cancer.
- Weight of normal Parathyroid glands in patients with Parathyroid adenomas.
- Manipulation of the primary Breast tumor and the incidence of sentinel node metastases from invasive Breast cancer.
- Sentinel lymph node dissection and the current status of American trials on Breast lymphatic mapping.
- Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in Cancer cells.
- Overexpression of glucosylceramide synthase and P-glycoprotein in Cancer cells selected for resistance to natural product chemotherapy.
- Accelerated partial Breast irradiation after conservative surgery for Breast cancer.
- The current role of sentinel node biopsy in the treatment of Breast cancer.
- Skin-sparing mastectomy. specialty bias and worldwide lack of consensus.
- Preoperative localization and radioguided Parathyroid surgery.
- The effects of adjuvant chemotherapy on bone density in postmenopausal women with early Breast cancer.
- The selective use of sentinel node biopsy in ductal Carcinoma in situ.
- Detection of tumor-specific genetic alterations in bone marrow from early-stage Breast cancer patients.
- Stanniocalcin-1: a novel molecular blood and bone marrow marker for human Breast cancer.
- Axillary dissection is not required for all patients with Breast cancer and positive sentinel nodes.
- Molecular lymphatic mapping of the sentinel lymph node.
- The time has come to change the algorithm for the surgical management of early Breast cancer.
- Tumor characteristics predictive of sentinel node metastases in 105 consecutive patients with invasive lobular Carcinoma.
- Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in Breast cancer cells.
Schools
University Of ChicagoThe Pritzker School Of Medicine
Uc San Francisco Med Center
UCLA Med Center
Procedures Preformed
- Appendectomy, Open
- Biopsy of Breast
- Breast Reconstruction
- Breast Surgical Procedure
- View All
Conditions Treated
- Anemia
- Breast Cancer
- Breast Diseases
- Breast Lump
- View All
Doctors Specialties
- Breast Surgical Oncology
- Complex General Surgical Oncology
- General Surgery
- Surgical Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Redbook Magazine: Top Breast Cancer Doctors
- Super Doctor
- Top MD
- Fellow (FACS)
- Most Compassionate Doctor
Education
-
UCSF -
University of Chicago Pritzker School of Medicine
Hospital
-
Cedars-Sinai Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356353577 |
| Last Name Of The Provider | GIULIANO |
| First Name Of The Provider | ARMANDO |
| View All |
Similar Doctors
|
Dr. Beth A. Moore, MD |
|
|
Dr. Catherine M. Dang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary M. Tearston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mari A. Madsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur M. Kahn, MD |
|
|
Dr. Atta M. Nawabi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott R. Karlan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan W. Silberman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Silvia Kurtovic, MD |
|
|
Dr. Alexandra Gangi, MD |
|
|
Dr. George Berci, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Cherisse D. Berry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Omar N. Hussain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heidi J. Reich, MD
This Doctor is OpenDoctor Recommended.
|